期刊文献+

肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值 被引量:44

Diagnostic Value of Multiple Tumor Marker Detection for Mature and Immature Teratoma of the Ovary
下载PDF
导出
摘要 背景与目的:卵巢成熟、未成熟畸胎瘤术前鉴别诊断较困难,本研究期望通过血清肿瘤标志物联合检测的方法,为其诊断及鉴别诊断提供有价值依据。方法:收集1995年1月至2005年12月在中山大学肿瘤防治中心初治并经病理确诊为单纯型卵巢畸胎瘤的272例患者的临床资料,统计分析血清糖链抗原125(carbohydrate antigen125,CA125)、糖链抗原153(CA153)、糖链抗原199(CA199)、神经元特异性烯醇化酶(neuron specific enolase,NSE)、甲胎蛋白(alpha-fetoprotein,AFP)、癌胚抗原(carcinoembryonic antigen,CEA)的检测水平在卵巢成熟及未成熟畸胎瘤中的差异。结果:254例卵巢成熟畸胎瘤患者,中位年龄30岁,血清CA125、CA153、CA199、NSE、AFP、CEA平均值分别为25.5×103u/L,11.8×103u/L,106.6×103u/L,12.6μg/L,2.7μg/L和2.5μg/L。18例卵巢未成熟畸胎瘤患者,中位年龄23岁,上述6项指标的平均值分别为140.3×103u/L,16.8×103u/L,112.0×103u/L,18.0μg/L,369.5μg/L和3.2μg/L。未成熟畸胎瘤患者血清中CA125、CA153、AFP平均水平及表达阳性率均高于成熟畸胎瘤患者,差异有统计学意义(P<0.05)。单独应用一项指标,CA125、CA153、AFP对未成熟畸胎瘤诊断性能的特异度均较高,而CA125的灵敏度最高(50.0%)。使用CA125、CA153、AFP三项指标联合检测明显提高了灵敏度(71.4%)。结论:术前肿瘤标志物,尤其是CA125、CA153、AFP联合检测对卵巢未成熟型与成熟型畸胎瘤的鉴别诊断有一定参考价值。 BACKGROUND & OBJECTIVE. It is difficult to differentially diagnose mature cystic teratoma (MCT) and immature teratoma (IT) of the ovary before operation. This study was to evaluate the value of multiple tumor marker detection in differential diagnosis of ovarian MCT and IT. METHODS; Clinical data of 272 patients with ovarian teratoma, diagnosed pathologically and treated at Cancer Center of Sun Yat-sen University from Jan. 1995 to Dec. 2005, were reviewed. Of the 272 patients, 254 had MCT and 18 had IT. The serum levels of carbohydrate antigen 125 (CA125), CA153, CA199, neuron-specific enolase (NSE), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) in MCT and IT were compared. RESULTS. Of the 254 patients with MCT, the median age was 30, the mean serum levels of CA125, CA153, CA199, NSE, AFP and CEA were 25.5×10^3 u/L, 11.8×10^3 u/L, 106.6×10^3 u/L, 12.6 μg/L, 2.7 μg/L and 2.5 μg/L. Of the 18 patients with IT, the median age was 23, the mean serum levels of these tumor markers were 140.3×10^3 u/L, 16.8×10^3 u/L, 112.0×10^3 u/L, 18.0 μg/L, 369.5 μg/L and 3.2 iJg/L. Both the serum levels and positive rates of CA125, CA153 and AFP were significantly higher in IT than in MCT (P〈 0.05). When detected alone to differentially diagnose MCT and IT, the specificity of CA125, CA153, AFP were high, and the sensitivity of CA125 was the best (50.0%). The sensitivity was elevated to 71.4% by combined detection of CA125, CA153 and AFP. CONCLUSION: Combined detection of tumor markers, especially CA125, CA153 and AFP, may be helpful for differential diagnosis of ovarian MCT and IT.
出处 《癌症》 SCIE CAS CSCD 北大核心 2008年第1期92-95,共4页 Chinese Journal of Cancer
关键词 卵巢肿瘤 成熟畸胎瘤 未成熟畸胎瘤 肿瘤标志物 诊断 Ovarian neoplasm Mature teratoma Immature teratoma Tumor marker Diagnosis
  • 相关文献

参考文献11

  • 1Calder C T, Light A M, Rollason T P. Immature ovarian teratoma with mature peritoneal metastatic deposits showing glial, epithelial and endometioid differentiation: a case report and review of the literature [J]. Gynecol Pathol, 1994,13(3): 279-282. 被引量:1
  • 2Gallion H, van Nagell J R Jr, Donaldson E S, et al. Immature teratoma of the ovary [J]. Am J Obstet Gynecol, 1983,146(4) : 361-365. 被引量:1
  • 3龚晓明,冷金花,郎景和,黄荣丽,刘珠凤,孙大为,朱兰.卵巢成熟畸胎瘤695例临床分析[J].中国医学科学院学报,2004,26(6):692-695. 被引量:51
  • 4Dede M, Gungor S, Yenen M C, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary [J]. Gynecol Cancer, 2006, 16( 1 ) : 189-193. 被引量:1
  • 5Kikkawa F, Nawa A, Tamakoshi K, et al. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary [J ]. Cancer, 1998,82 ( 11 ) : 2249-2255. 被引量:1
  • 6李福玉,韦福康,胡颖川,白令.小儿卵巢畸胎瘤伴腹膜神经胶质增多症3例[J].中国肿瘤临床,2001,28(4):302-302. 被引量:11
  • 7Malogolowkin M H, Ortega J A, Kralio M, et al. Immature teratomas: identification of patients at risk for malignant recurrence [J]. Natl Cancer Inst, 1989,81 ( 11 ) : 870-874. 被引量:1
  • 8连利娟主编..林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2000:768.
  • 9申桂华,姜展红,陈德新.血清肿瘤标记物测定在卵巢成熟畸胎瘤及其恶变者的临床应用[J].中国癌症杂志,2006,16(5):370-373. 被引量:7
  • 10Kawata M, Sekiya S, Hatakeyama R, et al. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma [J]. Gynecol Oncol, 1989,32(2):191-197. 被引量:1

二级参考文献15

  • 1龚晓明,冷金花,郎景和,黄荣丽,刘珠凤,孙大为,朱兰.卵巢成熟畸胎瘤695例临床分析[J].中国医学科学院学报,2004,26(6):692-695. 被引量:51
  • 2Nezhat C,Winer WK,Nezhat F,et al.Laparoscopic removal of dermoid cysts.Obstet Gynecol,1989,73:278 被引量:1
  • 3Mais V, Ajossa S, Mallarini G, et al. No recurrence of mature ovarian teratomas after laparoscopic cystectomy.BJOG,2003,110:624-626 被引量:1
  • 4Ayhan A, Bukulmez O, Genc C, et al. Mature cystic teratomas of the ovary: case series from one institution over 34years. Eur J Obstet Gynecol Reprod Biol, 2000, 88:153-157 被引量:1
  • 5Kikkawa F,Ishikawa H,Tamakoshi K,et al.Squamous cell carcinoma arising from mature cystic teratoma of the ovary:a clinicopathologic analysis[J].Obstet Gynecol,1997,89 (6):1017-1022. 被引量:1
  • 6Comerci JT,Licciardi FK,Bergh PL,et al.Mature cystic teratoma:A clinicopathologic evaluation of 517 cases and review of the literature[J].Obstet Gynecol,1994,84 (1):22-28. 被引量:1
  • 7Kawai M,Kano T,Kikkawa F,et al.Seven tumor markers in benign and malignant germ cell tumors of the ovary[J].Gynecol Oncol,1992,45 (3):248-253. 被引量:1
  • 8Kikkawa F,Nawa A,Tamakoshi,et al.Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary[J].Cancer,1998,82 (11):2249-2255. 被引量:1
  • 9Suzuki M,Tamura N,Kobayashi H,et al.Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary[J].Gynecol 0ncol,2000,77 (3):405-409. 被引量:1
  • 10Yoshioka T,Tanaka T.Immunohistochemical and meolecular studies on malignant transformation in mature cystic teratoma of the ovary[J].J Obstet Gynaecol Res,1998,24 (2):83-90. 被引量:1

共引文献63

同被引文献332

引证文献44

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部